Presenters: Dr. Merit Cudkowicz (Sean M. Healey & AMG Center for ALS at Mass General Hospital), Dr. Sabrina Paganoni (Sean M. Healey & AMG Center for ALS at Mass General Hospital), and Dr. Shafeeq Ladha (Barrow Neurological Institute)
The purpose of this webinar is to provide an overview of how SLS-005 (trehalose) may help to slow ALS and illustrate what potential participants can expect when enrolling in Regimen E of the Healey ALS Platform Trial. The presenters will review some of the unique aspects of the regimen related to the intravenous administration.
